Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Guardforce AI Co., Ltd. Announces Pricing of $15 Million Underwritten Public Offering and Nasdaq Listing 2021-09-29 07:00
WeTrade's Dixon Dai: Digital Economy is the Driven Force and Trend of New Age 2021-09-29 00:05
BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission 2021-09-28 20:00
Sun Lei, CEO of Luxventure, has been appointed as President of Cross-Border Merchants Association of Hainan Province 2021-09-27 21:36
ChipMOS to Present at Morgan Stanley Virtual Asia DDIC Symposium 2021-09-23 18:00
BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins 2021-09-23 15:00
Tingo Inc, Appoints John J. Brown and Christophe Francois Charlier as Co-Chair of the Company's Board of Directors 2021-09-23 10:44
Sasol commits to net zero ambition by 2050, triples 2030 GHG emission reduction targets 2021-09-22 22:07
Arçelik joins the UN Global Compact CFO Taskforce to align finance and sustainability for real world change 2021-09-22 18:48
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug 2021-09-22 18:45
Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial 2021-09-20 18:00
BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone 2021-09-17 15:00
Luxventure Entered into Agreement with Tianjin China Travel Cultural Development Company, a subsidiary of China Travel Services 2021-09-16 21:36
Sasol, Haldor Topsøe expand G2LTM licensing collaboration to grow sustainable synthetic fuels and chemicals globally 2021-09-15 20:23
WeTrade to Attend 2021 World Internet Conference 2021-09-15 19:00
10,000 green hydrogen generators per month: groundbreaking for Enapter electrolyser mass production in North Rhine-Westphalia 2021-09-15 04:25
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs 2021-09-14 15:00
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval 2021-09-13 19:00
ChipMOS REPORTS RECORD AUGUST 2021 REVENUE; 26.1% GROWTH YEAR OVER YEAR 2021-09-10 18:00
Ossen Innovation Announces Completion of Merger 2021-09-10 10:00
1 51 52 53 54 55 126